Prostate cancer screening reduces deaths by a fifth: Large, long-term European trial

7 agosto 2014

Screening for prostate cancer could reduce deaths from the disease by about a fifth, according to the long-term results of a major European study involving over 162 000 men. Despite this new evidence for the effectiveness of prostate-specific antigen (PSA) testing to reduce mortality, doubts as to whether the benefits of screening outweigh the harms remain, and routine PSA screening programmes should not be introduced at this time, conclude the authors.
http://feeds.sciencedaily.com/~r/sciencedaily/~3/XYWLTQkbRZA/140807105049.htm

Volver